Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death (original) (raw)

Original Paper
Published: 30 November 1999

Oncogene volume 18, pages 6965–6973 (1999)Cite this article

1129 Accesses
158 Citations
Metrics details

Abstract

Hepatitis B virus (HBV) X protein activates many viral and cellular genes in trans and functional disruption of the p53 tumor suppressor gene product occurs when X protein is transiently expressed in the cytoplasm of cultured cells. We have carried out investigations to determine the exact location of X protein in X gene transfected cells by using a fluorescent staining technique as well as by biochemical analyses. Aggregation of mitochondrial structures became evident at the periphery of nucleus in the cytoplasm of X transfected cells. X protein was found associated with the aggregated mitochondrial structures. Furthermore, transiently expressed p53 protein co-localized with X protein in X transfected cells. However, the appearance of aggregated mitochondrial structures at the nuclear periphery was independent of the presence of p53 protein in X transfected cells. X protein expression also caused an appearance of TUNEL positive nucleus, cytochrome c release from mitochondrial, the decrease of mitochondrial membrane potential and the membrane blebbing of X transfected cells, which are characteristic of cell death. Our data suggest that X protein causes an abnormal aggregation of mitochondrial structures in the cell, which may be eventually connected with cell death.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Purchase on SpringerLink
Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

Arii M, Takada S and Koike K. . 1992 Oncogene 7: 397–403.
Benn J and Schneider RT. . 1994 Proc. Natl. Acad. Sci. USA 91: 10350–10354.
Cross JC, Wen P and Rutter WJ. . 1993 Proc. Natl. Acad. Sci. USA 90: 8078–8082.
Ganem D and Varmus HE. . 1987 Annu. Rev. Biochem. 56: 651–695.
Hohne M, Schaefer S, Scifer M, Feitelson MA, Paul D and Gerlich WH. . 1990 EMBO J. 9: 1137–1145.
Kekule AS, Lauer U, Weiss L, Luber B and Hofschneider PH. . 1993 Nature 361: 742–745.
Kim C-M, Koike K, Saito I, Miyamura T and Jay G. . 1991 Nature 351: 317–320.
Kim DW, Uetsuki T, Kaziro K, Yamaguchi N and Sugano S. . 1990 Gene 91: 217–223.
Maguire HF, Hoeffler JP and Siddiqui A. . 1991 Science 252: 842–844.
Masuda H, Miller C, Koeffler HP, Battifora H and Cline MJ. . 1987 Proc. Nat. Acad. Sci. USA 84: 7716–7719.
Natoli G, Avantaggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C and Levrero M. . 1994a Mol. Cell. Biol. 14: 989–998.
Natoli G, Avantaggiati ML, Chirillo P, Puri P, Ianni A, Balsano C and Levrero M. . 1994b Oncogene 9: 2837–2843.
Petit PX, Susin S-A, Zamzami N, Mignotte B and Kroemer G. . 1996 FEBS Lett. 396: 7–13.
Rakotomahanina CK, Hilger C, Fink T, Zentgraf H and Schroder CH. . 1994 Oncogene 9: 2613–2621.
Reed JC. . 1997 Nature 387: 773–776.
Rossner MT. . 1992 J. Med. Virol. 36: 101–117.
Sambrook J, Fritsch EF and Maniatis T. . (1989) In: Molecular Cloning: A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
Google Scholar
Shaulsky G, Goldfinger N, Tosky MS, Levine AJ and Rotter V. . 1991 Oncogene 6: 2055–2065.
Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M and Koike K. . 1989 Jpn. J. Cancer Res. 80: 617–621.
Spandau DF and Lee C-H. . 1988 J. Virol. 62: 427–434.
Takada S, Kaneniwa N, Tsuchida N and Koike K. . 1997 Oncogene 15: 1895–1901.
Takada S, Kido H, Fukutomi A, Mori T and Koike K. . 1994 Oncogene 9: 341–348.
Takada S and Koike K. . 1990 Jpn. J. Cancer Res. 81: 1191–1194.
Takada S and Koike K. . 1994 Virology 205: 503–510.
Tanaka S and Koike K. . 1978 Biochim. Biophys. Res. Comm. 81: 791–797.
Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A and Hirokawa N. . 1998 Cell 93: 1147–1158.
Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon M-L, Tiollais P and Buendia MA. . 1998 Oncogene 17: 2115–2123.
Tiollais P, Pourcel C and Dejean A. . 1985 Nature 317: 489–495.
Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB. . 1997 Cell 91: 627–637.
Yaffe MP. . 1999 Science 283: 1493–1497.

Download references

Acknowledgements

We thank VP Iyemere for reading the manuscript and M Kobayashi for preparing the manuscript. This work was supported partly by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture and a Grant-in-Aid from the Ministry of Health and Welfare, Japan to K Koike. The work was also supported partly by a grant from Mitsui Life Social Welfare Foundation, Tokyo, Japan to K Koike.

Author information

Author notes

Shinako Takada
Present address: Department of Molecular and Cellular Biology, Howard Hughes Medical Institute, University of California, Berkeley, California, CA 94720, USA
Shinako Takada: S Takada and Y Shirakata contributed equally to this work

Authors and Affiliations

Department of Gene Research, The Cancer Institute, (JFCR), Kami-Ikebukuro, Toshima-ku, Tokyo, 170-8455, Japan
Shinako Takada, Yumiko Shirakata, Noriko Kaneniwa & Katsuro Koike

Authors

Shinako Takada
Yumiko Shirakata
Noriko Kaneniwa
Katsuro Koike

Rights and permissions

About this article

Cite this article

Takada, S., Shirakata, Y., Kaneniwa, N. et al. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death.Oncogene 18, 6965–6973 (1999). https://doi.org/10.1038/sj.onc.1203188

Download citation

Received: 02 February 1999
Revised: 23 August 1999
Accepted: 25 August 1999
Published: 30 November 1999
Issue date: 25 November 1999
DOI: https://doi.org/10.1038/sj.onc.1203188